Qiagen NV | QIA - Debt

Stock Price
43.17
Daily Change
-0.31 -0.70%
Monthly
1.90%
Yearly
8.86%
Q1 Forecast
43.53

Qiagen NV reported $2.13B in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
argenx SE USD 43.15M 4.1M Jun/2025
Avita Medical AUD 44.59M 1.4M Jun/2025
Dianthus Therapeutics USD 1.28M 45K Sep/2025
Ionis Pharmaceuticals USD 1.23B 192.99M Sep/2025
IQVIA Holdings USD 15.72B 767M Dec/2025
Moderna USD 741M 4M Jun/2025
Organon & Co USD 8.83B 68M Sep/2025
Qiagen NV USD 2.13B 683.16M Sep/2025
Revvity USD 3.37B 5.86M Sep/2025
Tectonic Therapeutic USD 876K 115K Dec/2024
Viatris USD 14.44B 318.8M Sep/2025
Xeris Pharmaceuticals USD 257.65M 431K Sep/2025